FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Tangney

Research Profile

Living Beings

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
V Boncheva; S A Bonney; S E Brooks; A Mirnezami; G O'Sullivan; Mark Tangney; Barbara Guinn
New targets for the immunotherapy of colon cancer-does reactive disease hold the answer?
M Cronin; Kevin P Francis; R M Stanton; Mark Tangney
Bacterial vectors for imaging and cancer gene therapy: a review.
James W Collins; Kevin P Francis; Artemis Kosta; Mark Tangney; Ning Zhang; Ali R Akin; Gad Frankel
Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Tangney (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: V Boncheva; S A Bonney; S E Brooks; A Mirnezami; G O'Sullivan; Mark Tangney; Barbara Guinn
New targets for the immunotherapy of colon cancer-does reactive disease hold the answer?
Cancer gene therapy 2013;20(3):157-68.
2012: M Cronin; Kevin P Francis; R M Stanton; Mark Tangney
Bacterial vectors for imaging and cancer gene therapy: a review.
Cancer gene therapy 2012;19(11):731-40.
2012: James W Collins; Kevin P Francis; Artemis Kosta; Mark Tangney; Ning Zhang; Ali R Akin; Gad Frankel
Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity.
Microbiology (Reading, England) 2012;158(Pt 11):2826-34.
2012: Mark Tangney
Editorial: in vivo imaging & gene therapy.
Current gene therapy 2012;12(1):1.
2012: Sara A Collins; Kei Hiraoka; Akihito Inagaki; Noriyuki Kasahara; Mark Tangney
PET imaging for gene & cell therapy.
Current gene therapy 2012;12(1):20-32.
2012: Mark Tangney; Kevin P Francis
In vivo optical imaging in gene & cell therapy.
Current gene therapy 2012;12(1):2-11.
2012: Chwanrow K Baban; Michelle Cronin; Kevin P Francis; Xuefeng Gao; Anne O'Brien; Sabin Tabirca; Ali R Akin; Mark Tangney
Bioluminescent bacterial imaging in vivo.
Journal of visualized experiments : JoVE 2012;(69):e4318.
2012: Sarfraz Ahmad; Gerald C Sullivan; Paul Sweeney; Mark Tangney
DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?
Genetic vaccines and therapy 2012;10(1):9.
2012: David Morrissey; Gerald C O'Sullivan; Simon Rajendran; Garrett Casey; Sara A Collins; Jan-Peter van Pijkeren; Mark Tangney
Control and augmentation of long-term plasmid transgene expression in vivo in murine muscle tissue and ex vivo in patient mesenchymal tissue.
Journal of biomedicine & biotechnology 2012;2012():379845.
2012: Michelle Cronin; Kevin P Francis; Cormac G M Gahan; Susan A Joyce; Noriyuki Kasahara; Jae-Beom Kim; Jeff Meganck; Gerald C O'Sullivan; Ali R Akin; Chwanrow K Baban; Sara A Collins; Gooitzen M van Dam; Douwe van Sinderen; Ning Zhang; Mark Tangney
High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting.
PloS one 2012;7(1):e30940.
2011: M G Bourke; J Kevin Collins; M de Kruijf; P F Forde; K J Harrington; M J Kucharczyk; S Salwa; Declan M Soden; Mark Tangney; Gerald C O'Sullivan
The emerging role of viruses in the treatment of solid tumours.
Cancer treatment reviews 2011;37(8):618-32.
2011: Sarfraz Ahmad; Garrett Casey; Michelle Cronin; Simon Rajendran; Paul Sweeney; Mark Tangney; Gerald C O'Sullivan
Induction of effective antitumor response after mucosal bacterial vector mediated DNA vaccination with endogenous prostate cancer specific antigen.
The Journal of urology 2011;186(2):687-93.
2011: Simon Rajendran; Sara Collins; Jan-Peter van Pijkeren; Deirdre O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Targeting of breast metastases using a viral gene vector with tumour-selective transcription.
Anticancer research 2011;31(5):1627-35.
2011: Simon Rajendran; Deirdre O'Hanlon; David Morrissey; Tracey O'Donovan; Gerald C O'Sullivan; Mark Tangney
Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.
Experimental biology and medicine (Maywood, N.J.) 2011;236(4):423-34.
2010: Chwanrow K Baban; Michelle Cronin; Deirdre O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Bacteria as vectors for gene therapy of cancer.
Bioengineered bugs 2010;1(6):385-94.
2010: Michelle Cronin; David Morrissey; Simon Rajendran; Shereen M El Mashad; Douwe van Sinderen; Gerald C O'Sullivan; Mark Tangney
Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.
Molecular therapy : the journal of the American Society of Gene Therapy 2010;18(7):1397-407.
2010: Maria Whelan; Garrett Casey; M MacConmara; J A Lederer; Declan M Soden; J Kevin Collins; Mark Tangney; Gerald C O'Sullivan
Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation.
Cancer gene therapy 2010;17(7):501-11.
2010: Mark Tangney; Sarfraz Ahmad; Sara A Collins; Gerald C O'Sullivan
Gene therapy for prostate cancer.
Postgraduate medicine 2010;122(3):166-80.
2010: Jan-Peter van Pijkeren; David Morrissey; Ian R Monk; Michelle Cronin; Simon Rajendran; Gerald C O'Sullivan; Cormac G M Gahan; Mark Tangney
A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy.
Human gene therapy 2010;21(4):405-16.
2010: Garrett Casey; James P Cashman; David Morrissey; Maria C Whelan; John O Larkin; Declan M Soden; Mark Tangney; Gerald C O'Sullivan
Sonoporation mediated immunogene therapy of solid tumors.
Ultrasound in medicine & biology 2010;36(3):430-40.
2010: Mark Tangney; Cormac G M Gahan
Editorial [Hot Topic: Bacterial Vectors for Gene & Cell Therapy].
Current gene therapy 2010;10(1):1-2.
2010: Mark Tangney; Cormac G M Gahan
Listeria monocytogenes as a vector for anti-cancer therapies.
Current gene therapy 2010;10(1):46-55.
2010: David Morrissey; Gerald C O'Sullivan; Mark Tangney
Tumour targeting with systemically administered bacteria.
Current gene therapy 2010;10(1):3-14.
2010: Simon Rajendran; Slawomir Salwa; Xuefeng Gao; Sabin Tabirca; Deirdre O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Ex vivo culture of patient tissue & examination of gene delivery.
Journal of visualized experiments : JoVE 2010;(46):.
2010: Sara A Collins; Alexandra Buhles; MF Scallan; Patrick T Harrison; Deirdre M O'Hanlon; Gerald C O'Sullivan; Mark Tangney
AAV2-mediated in vivo immune gene therapy of solid tumours.
Genetic vaccines and therapy 2010;8():8.
2010: Simon Rajendran; Slawomir Salwa; Xuefeng Gao; Sabin Tabirca; Deirdre O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Murine bioluminescent hepatic tumour model.
Journal of visualized experiments : JoVE 2010;(41):.
2010: Sarfraz Ahmad; Garrett Casey; Paul Sweeney; Mark Tangney; Gerald C O'Sullivan
Optimised electroporation mediated DNA vaccination for treatment of prostate cancer.
Genetic vaccines and therapy 2010;8(1):1.
2009: Sarfraz Ahmad; Garrett Casey; Paul Sweeney; Mark Tangney; Gerald C O'Sullivan
Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(6):1101-8.
2009: Alexandra Buhles; Sara A Collins; Jan P van Pijkeren; Simon Rajendran; Michelle Miles; Gerald C O'Sullivan; Deirdre M O'Hanlon; Mark Tangney
Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours.
Genetic vaccines and therapy 2009;7():5.
2008: J P Cashman; John O Larkin; Garrett Casey; Maria Whelan; C Collins; Simon Aarons; Mark Tangney; Gerald C O'Sullivan
Immune gene therapy as a neoadjuvant to surgical excision to control metastatic cancers.
Cancer letters 2008;262(1):94-102.
2008: Sara A Collins; Barbara Guinn; Patrick T Harrison; MF Scallan; Gerald C O'Sullivan; Mark Tangney
Viral vectors in cancer immunotherapy: which vector for which strategy?
Current gene therapy 2008;8(2):66-78.
2008: John O Larkin; Garrett D Casey; Mark Tangney; James Cashman; Chris G Collins; Declan M Soden; Gerald C O'Sullivan
Effective tumor treatment using optimized ultrasound-mediated delivery of bleomycin.
Ultrasound in medicine & biology 2008;34(3):406-13.
2007: Christian U Riedel; Ian Monk; Pat G Casey; David Morrissey; Gerald C O'Sullivan; Mark Tangney; Colin Hill; Cormac G M Gahan
Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro.
Applied and environmental microbiology 2007;73(9):3091-4.
2007: John O Larkin; Chris G Collins; Simon Aarons; Mark Tangney; Maria Whelan; Seamus O'Reily; Oscar Breathnach; Declan M Soden; Gerald C O'Sullivan
Electrochemotherapy: aspects of preclinical development and early clinical experience.
Annals of surgery 2007;245(3):469-79.
2006: Chris G Collins; Mark Tangney; John O Larkin; Garrett Casey; Maria Whelan; J Cashman; J Murphy; Declan M Soden; Susanne Vejda; S McKenna; Barry Kiely; J Kevin Collins; J Barrett; Simon Aarons; Gerald C O'Sullivan
Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors.
Cancer gene therapy 2006;13(12):1061-71.
2006: M Walsh; Mark Tangney; M J O'Neill; John O Larkin; Declan M Soden; Sharon L McKenna; Raphael Darcy; Gerald C O'Sullivan; Caitriona M O'Driscoll
Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: implications for cancer gene therapy.
Molecular pharmaceutics 2006;3(6):644-53.
2006: Mark Tangney; Garrett Casey; John O Larkin; Chris G Collins; Declan M Soden; J Cashman; Maria Whelan; Gerald C O'Sullivan
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease.
Cancer immunology, immunotherapy : CII 2006;55(11):1443-50.
2006: Declan M Soden; John O Larkin; Chris G Collins; Mark Tangney; Simon Aarons; John Piggott; Anthony Morrissey; Colum Dunne; Gerald C O'Sullivan
Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours.
Cancer letters 2006;232(2):300-10.
2006: John Larkin; Mark Tangney; Chris Collins; Garrett Casey; Michael G O'Brien; Declan M Soden; Gerald C O'Sullivan
Oral immune tolerance mediated by suppressor T cells may be responsible for the poorer prognosis of foregut cancers.
Medical hypotheses 2006;66(3):541-4.
2005: John Larkin; Declan M Soden; Chris Collins; Mark Tangney; J M Preston; L J Russell; A P McHale; Colum Dunne; Gerald C O'Sullivan
Combined electric field and ultrasound therapy as a novel anti-tumour treatment.
European journal of cancer (Oxford, England : 1990) 2005;41(9):1339-48.
2004: Pat G Casey; Derek Butler; Gillian E Gardiner; Mark Tangney; Paul Simpson; Peadar G Lawlor; Catherine Stanton; R Paul Ross; Colin Hill; Gerald F Fitzgerald
Salmonella carriage in an Irish pig herd: correlation between serological and bacteriological detection methods.
Journal of food protection 2004;67(12):2797-800.
2004: Pat G Casey; Garrett Casey; Gillian E Gardiner; Mark Tangney; Catherine Stanton; R Paul Ross; Colin Hill; Gerald F Fitzgerald
Isolation and characterization of anti-Salmonella lactic acid bacteria from the porcine gastrointestinal tract.
Letters in applied microbiology 2004;39(5):431-8.